These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10980858)

  • 21. Emerging concepts in the pharmacogenomics of arrhythmias: ion channel trafficking.
    Harkcom WT; Abbott GW
    Expert Rev Cardiovasc Ther; 2010 Aug; 8(8):1161-73. PubMed ID: 20670193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classification and action of antiarrhythmic drugs.
    Borchard U; Berger F; Hafner D
    Eur Heart J; 1989 Sep; 10 Suppl E():31-40. PubMed ID: 2478366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Why are some antiarrhythmic drugs proarrhythmic? Cardiac arrhythmia study by bifurcation analysis.
    Chay TR
    J Electrocardiol; 1995; 28 Suppl():191-7. PubMed ID: 8656110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiarrhythmic drugs and cardiac ion channels: mechanisms of action.
    Carmeliet E; Mubagwa K
    Prog Biophys Mol Biol; 1998; 70(1):1-72. PubMed ID: 9785957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perspectives on the current treatment of cardiac arrhythmias.
    Bigger JT
    Am J Cardiol; 1984 Aug; 54(4):2B-7B. PubMed ID: 6147081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Classification and mechanism of action of anti-arrhythmia drugs].
    Gasic S
    Wien Med Wochenschr; 1994; 144(14-15):338-42. PubMed ID: 7825324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel targets for cardiac antiarrhythmic drug development.
    Hesketh JC; Herrera D; Zicha S; Nattel S
    Curr Pharm Des; 2005; 11(15):1959-74. PubMed ID: 15974970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New fields of research in pharmacological antiarrhythmic therapy].
    Hatem S
    Arch Mal Coeur Vaiss; 2004 Nov; 97(11):1054-7. PubMed ID: 15609906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiology of ion channels of the heart.
    Ravens U; Wettwer E; Ohler A; Amos GJ; Mewes T
    Fundam Clin Pharmacol; 1996; 10(4):321-8. PubMed ID: 8871130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Taurine-magnesium coordination compound, a potential anti-arrhythmic complex, improves aconitine-induced arrhythmias through regulation of multiple ion channels.
    Lou J; Wu H; Wang L; Zhao L; Li X; Kang Y; Wen K; Yin Y
    Toxicol Appl Pharmacol; 2018 Oct; 356():182-190. PubMed ID: 30125596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of antiarrhythmic drugs on the hyperpolarization-activated cyclic nucleotide-gated channel current.
    Tamura A; Ogura T; Uemura H; Reien Y; Kishimoto T; Nagai T; Komuro I; Miyazaki M; Nakaya H
    J Pharmacol Sci; 2009 Jun; 110(2):150-9. PubMed ID: 19498275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The working classification of antiarrhythmic drugs based on the pathogenetic approach to treatment of cardiac arrhythmias].
    Lipnitskiĭ TN; Kozlovskiĭ VA
    Lik Sprava; 2002; (8):26-30. PubMed ID: 12669534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of antiarrhythmic drugs on canine ventricular arrhythmia models: which electrophysiological characteristics of drugs are related to their effectiveness?
    Hashimoto K; Haruno A; Matsuzaki T; Sugiyama A; Akiyama K
    Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():805-17. PubMed ID: 1657110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ["Sicilian gambit": pathophysiological approach to drug therapy of arrhythmia (lecture]].
    Sulimov VA
    Ter Arkh; 1999; 71(8):67-74. PubMed ID: 10515042
    [No Abstract]   [Full Text] [Related]  

  • 35. Ionic mechanisms for prolongation of refractoriness and their proarrhythmic and antiarrhythmic correlates.
    Roden DM
    Am J Cardiol; 1996 Aug; 78(4A):12-6. PubMed ID: 8780324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consequences of the Sicilian Gambit.
    Rosen MR
    Eur Heart J; 1995 Aug; 16 Suppl G():32-6. PubMed ID: 8595798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiarrhythmic agents: current status and perspectives.
    Mátyus P; Varró A; Papp JG; Wamhoff H; Varga I; Virág L
    Med Res Rev; 1997 Sep; 17(5):427-51. PubMed ID: 9276860
    [No Abstract]   [Full Text] [Related]  

  • 38. New drugs vs. old concepts: a fresh look at antiarrhythmics.
    Thireau J; Pasquié JL; Martel E; Le Guennec JY; Richard S
    Pharmacol Ther; 2011 Nov; 132(2):125-45. PubMed ID: 21420430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New aspects of the electrophysiologic effect of antiarrhythmic agents].
    Antoni H; Weirich J
    Herz; 1990 Apr; 15(2):61-9. PubMed ID: 2188893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanistic and therapeutic perspectives for cardiac arrhythmias: beyond ion channels.
    Wu Y; Li J; Xu L; Lin L; Chen YH
    Sci China Life Sci; 2017 Apr; 60(4):348-355. PubMed ID: 28349303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.